In an interview with ONCOLOGY®, Elizabeth Travers, PharmD, BCOP, offers a comprehensive review of real-world treatment considerations of asciminib as therapy for patients with chronic myeloid leukemia.
Elizabeth Travers, PharmD, BCOP
Advertisement
Articles by Elizabeth Travers, PharmD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC
2
Tarlatamab May Offer New SOC for Relapsed ES-SCLC With Brain Metastases
3
Which Therapy Has the Best Efficacy in Transplant-Ineligible NDMM?
4
Companion Diagnostic Earns FDA Approval for Imlunestrant in Breast Cancer
5
